Publication | Closed Access

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer

Concomitant Stereotactic ReirradiationNeck CancerRadiation TherapyMedicineNasopharyngeal CancerHead And Neck CancerHead And Neck Squamous Cell CarcinomaHead And Neck SurgeryRecurrent HeadNeck OncologyRadiation OncologyOncologyHead And Neck OncologyCancer ResearchRadiologyHealth Sciences